Print Page | Sign In | Join
News & Press: Industry Events

Hundreds of Florida's Life Science Leaders to Convene at BioFlorida Annual Conference

Thursday, October 4, 2018   (0 Comments)
Share |

For more information:

Courtney Cox, PR Counsel

BioFlorida

(850) 224-0174 or CourtneyC@TheMooreAgency.com 

 

 

Hundreds of Florida's Life Science Leaders to Convene at  

BioFlorida Annual Conference

Annual Conference Showcases Advancements & Drives Growth of the Life Sciences Industry in Florida

 

 

FT. LAUDERDALE, FL (October 3, 2018) - Hundreds of Florida's executives, scientists, researchers, investors, legislators, and service providers from the biopharmaceutical, medical device, and healthIT industry will gather October 14-16 at The Westin Fort Lauderdale Beach Resort to hear from experts on recent industry trends, connect with investors and potential partners, and celebrate Florida innovation and achievements-all to continue the growth of the industry in the state.

BioFlorida, the statewide association supporting the advancement of the life sciences, represents 6,200 establishments and research organizations attracting the largest and most prestigious life sciences community in the state. The industry consists of just over 87,000 direct jobs with an average salary of $78,000 (TEConomy/BIO - 2018). The number of companies in Florida's biotechnology industry grew 14.7% in 2017 alone, making it one of the stronger growth years since 2008 and bringing the total number of biotechnology companies to 343 with 57 new companies added this year (BioFlorida BioDatabase).

The 21st BioFlorida Annual Conference will feature recent scientific and business achievements, explore high-impact public policy initiatives, drive partnerships, and will include a special focus on Latin America and potential areas of collaboration. Three distinct, interactive programming tracks-BioScience, BioTrends, and BioBusiness-will offer attendees timely insights while showcasing the momentum and ingenuity of Florida's life sciences industry.

 

  • Prominent keynote speakers:
    • Gregory Frost, PhD, Chairman & CEO, F1 Oncology
    • Graham Brazier, Vice President, Business Development, Bristol-Myers Squibb
    • Senator Lori Berman, Florida State Senate
  • The Founder/CEO Panel: Case Studies from Florida's Experts showcases pathways to success and advice to entrepreneurs from CEO/Founders leading Florida's life science industry, including John Engels, Investor & Co-Founder, AxoGen, Inc.; Maurice R. Ferré, MD, CEO & Chairman, INSIGHTEC; Robert G. Finizio, CEO, Co-Founder & Director, TherapeuticsMD, Inc.; and, Stephen C. Glover, Co-Founder, CEO & Chairman, Variant Pharmaceuticals, Inc. to share best practices from the field.
  •  A focus on Latin America featuring Latin America Industry Dynamics and Collaboration with Latin America: Expanding Florida's Life Science Footprint.
  • BioScience sessions featuring Florida's areas of strength and top researchers and most innovative companies: regenerative medicine, neurosciences, and cancer.
  • BioTrend sessions highlighting the latest trends in the life sciences: Expanding Role of Hospital Centers: Research and Patient Focus, Advancing Research: Keys to Successful Spin Outs and Partnerships, Next Generation Medical Technology, and HealthIT Advancements: Going Digital to Improve Healthcare & Treatment.
  • BioBusiness sessions highlighting company successes and providing entrepreneurial and executive level support in funding, commercialization, pricing and reimbursement including: Roadmap to Commercialization, Investment Strategy: How to Win a Pitch, and Value-Based Pricing and Reimbursement Realities in 2018.
  • Spotlight on Innovation features the following four companies that have met significant milestones over the last year: TherapeuticsMD (Boca Raton), CTD Holdings, Inc. (Gainesville), HedgePath Pharmaceuticals, Inc. (Tampa), and Hesperos, Inc. (Orlando).
  • The BioPitch Competition features 16 seed and early-stage companies who will compete during closed-door sessions with 16 investors before four finalists are selected to present at the General Session on Tuesday morning. The semi-finalists include: Antibiotic Adjuvant (Gainesville), Aventusoft (Boca Raton), Celigenex (Fort Lauderdale), Dalent Medical (Coral Gables), HealthSteps (Gainesville), KynderMed (Tallahassee), M:14;22-33 (Gainesville), Moterum Technologies (Seneca, SC), Nutent Therapeutics (Boca Raton), RashEndZ (St. Petersburg), Resility Health (Jacksonville), Simple Foods Collaborative Company (Hallandale Beach), STAT3 Therapeutics (Coral Springs), Stuart Therapeutics (Stuart), ThNA BioSciences (Tampa), and Vestion (Miami).
  • Award Ceremony recognizing the most successful companies and entrepreneurs in the state. Specific awards include: BioFlorida Leadership Award, Company of the Year Award, Entrepreneur of the Year Award, and the BioFlorida Lifetime Achievement Award.
  • CEO, Research, and Incubator Forums that will bring together peers from across the state to share best practices and facilitate collaboration.

 

To view full agenda or to register, visit https://bit.ly/2NcFHgq. To receive your media credentials to attend this event, please email Courtney Cox at CourtneyC@TheMooreAgency.com.

 

# # #

 

About BioFlorida

BioFlorida is the voice of Florida's life science industry, representing 6,200 establishments and research organizations in the biopharmaceutical, medical technology, HealthIT and bioagriculture sectors that collectively employ just over 87,000 Floridians (TEConomy/BIO - 2018). BioFlorida's member driven initiatives provide a strong business climate for the advancement of innovative products and technology that improve lives and promote economic benefits to the state.

The BioFlorida BioDatabase is a searchable resource which includes the latest information on Florida's bioscience industry and unique profiles of biopharmaceutical and biomedical technology companies. The location of all BioFlorida BioDatabase companies is also shown on a distribution map. The BioDatabase follows the industry-held standard of defining a biotechnology company according to the Ernst & Young guidelines that include core R&D and involve the use of modern biological techniques to develop products or services for human health care, animal health care, agricultural productivity, food processing, renewable resources, industrial manufacturing and environmental management. The BioFlorida BioDatabase does not include healthcare services companies, medical device companies without a biocomponent or biomed companies that are involved only in manufacturing and/or distribution of products.

About BioFlorida

BioFlorida represents 6,200 establishments and research organizations in the biopharmaceuticals, medical technology, healthIT and bioagriculture sectors that collectively employ 87,000 Floridians.

 

Members of the BioFlorida network include emerging and established life science companies, universities, research institutions, hospitals, medical centers, incubators, economic development agencies, investors and service providers.

 

NEW regional sponsorship opportunities available.

Connect